(Q46016026)
Statements
1 reference
Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. (English)
1 reference
Edith A Perez
1 reference
Adam M Brufsky
1 reference
Linda D Bosserman
1 reference
Richard R Caradonna
1 reference
Barbara B Haley
1 reference
C Michael Jones
1 reference
Halle C F Moore
1 reference
Lixian Jin
1 reference
Ghulam M Warsi
1 reference
Solveig G Ericson
1 reference
1 May 2009
1 reference
9
1 reference
2
1 reference
77-85
1 reference